PHLDA1 Expression is Controlled by an Estrogen Receptor (ER)-NFκB-miR-181 Regulatory Loop and is Essential for Formation of ER+ Mammospheres

[1]  Iannis Aifantis,et al.  Notch signaling: switching an oncogene to a tumor suppressor. , 2014, Blood.

[2]  Amit Sharma,et al.  DNASU plasmid and PSI:Biology-Materials repositories: resources to accelerate biological research , 2013, Nucleic Acids Res..

[3]  T. Sun,et al.  Plasmid-based target protectors allow specific blockade of miRNA silencing activity in mammalian developmental systems , 2013, Front. Cell. Neurosci..

[4]  J. Lebrun,et al.  Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. , 2013, Cellular signalling.

[5]  R. Agami,et al.  Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer , 2013, Cell cycle.

[6]  William P Schiemann,et al.  TGF-β upregulates miR-181a expression to promote breast cancer metastasis. , 2013, The Journal of clinical investigation.

[7]  S. Henderson,et al.  The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. , 2012, Blood.

[8]  Z. Szallasi,et al.  Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. , 2012, Endocrine-related cancer.

[9]  R. Giffard,et al.  miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. , 2012, Mitochondrion.

[10]  J. Frasor,et al.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. , 2012, Molecular endocrinology.

[11]  J. Frasor,et al.  CBP Mediates NF-κB-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter , 2011, Molecular and Cellular Biology.

[12]  S. Badve,et al.  PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer , 2011, Journal of Cell Science.

[13]  M. Lisanti,et al.  The role of breast cancer stem cells in metastasis and therapeutic implications. , 2011, The American journal of pathology.

[14]  Thomas M Green,et al.  A public genome-scale lentiviral expression library of human ORFs , 2011, Nature Methods.

[15]  R. Jorissen,et al.  PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. , 2011, Cancer research.

[16]  Joshua LaBaer,et al.  PSI:Biology-materials repository: a biologist’s resource for protein expression plasmids , 2011, Journal of Structural and Functional Genomics.

[17]  Robin L. Jones,et al.  Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer , 2010, Journal of Clinical Pathology.

[18]  E. Lander,et al.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling , 2010, Proceedings of the National Academy of Sciences.

[19]  Charles M. Perou,et al.  Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer , 2010, PloS one.

[20]  J. Frasor,et al.  Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements*♦ , 2010, The Journal of Biological Chemistry.

[21]  J. Frasor,et al.  Estrogen Promotes Breast Cancer Cell Survival in an Inhibitor of Apoptosis (IAP)-dependent Manner , 2010, Hormones & cancer.

[22]  E. van Marck,et al.  Is there a role for mammary stem cells in inflammatory breast carcinoma? , 2010, Cancer.

[23]  Robin L. Jones,et al.  Nuclear NF-kb/p65 expression and response to neoadjuvant chemotherapy in breast cancer. , 2010 .

[24]  F. Bertucci,et al.  Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer , 2009, Clinical Cancer Research.

[25]  H Aburatani,et al.  Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells , 2009, British Journal of Cancer.

[26]  J. Frasor,et al.  Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. , 2009, Cancer research.

[27]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[28]  Yanhui Hu,et al.  Protein Structure Initiative Material Repository: an open shared public resource of structural genomics plasmids for the biological community , 2009, Nucleic Acids Res..

[29]  V. Beneš,et al.  Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. , 2009, Cancer research.

[30]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[31]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[32]  R. Clarke,et al.  Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits? , 2009, Journal of Mammary Gland Biology and Neoplasia.

[33]  Sendurai A Mani,et al.  The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies , 2009, Journal of Mammary Gland Biology and Neoplasia.

[34]  J. Frasor,et al.  Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines. , 2008, Endocrinology.

[35]  D. Birnbaum,et al.  Cancer Stem Cells in Breast: Current Opinion and Future Challenges , 2008, Pathobiology.

[36]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[37]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[38]  A. Allan,et al.  Cancer stem cells: implications for the progression and treatment of metastatic disease , 2007, Journal of cellular and molecular medicine.

[39]  A. Schier,et al.  Target Protectors Reveal Dampening and Balancing of Nodal Agonist and Antagonist by miR-430 , 2007, Science.

[40]  M. Karin,et al.  IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells , 2007, Proceedings of the National Academy of Sciences.

[41]  Urs Eppenberger,et al.  Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer , 2007, BMC Cancer.

[42]  G. Petsko.  Transformation , 2006, Genome Biology.

[43]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[44]  A. Sahin,et al.  Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion , 2005, Molecular Cancer.

[45]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[46]  Urs Eppenberger,et al.  Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers , 2005 .

[47]  R. Clarke,et al.  The nuclear factor κB inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)–induced apoptosis in antiestrogen-resistant breast cancer cells , 2005, Molecular Cancer Therapeutics.

[48]  U. Kalinke,et al.  A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activation. , 2004, Gene.

[49]  D. Leroith,et al.  TDAG51 Mediates the Effects of Insulin-like Growth Factor I (IGF-I) on Cell Survival* , 2004, Journal of Biological Chemistry.

[50]  W. Friedrichs,et al.  NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[52]  Y. Inoue,et al.  Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts. , 2013, The Journal of investigative dermatology.

[53]  B. Katzenellenbogen,et al.  A MicroRNA196a2* and TP63 Circuit Regulated by Estrogen Receptor-α and ERK2 that Controls Breast Cancer Proliferation and Invasiveness Properties , 2012, Hormones and Cancer.

[54]  M. Karin,et al.  IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Robert Clarke,et al.  The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells. , 2005, Molecular cancer therapeutics.

[56]  C. Benz,et al.  Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. , 2005, The international journal of biochemistry & cell biology.

[57]  Susan S. Taylor,et al.  Target Protectors Reveal Dampening and Balancing of Nodal Agonist and Antagonist by miR-430 , 2022 .